AstraZeneca has added to its oncology pipeline by licensing a small-molecule KRAS inhibitor from Chinese biotech Usynova for $24 million upfront. The compound – called UA022 – targets the ...
1d
Tasting Table on MSN15 Discontinued Candies We'd Love To Bring BackWhile countless candies have come and gone throughout history, some now-defunct candy items stand out. Here are 15 ...
Recipe Master on MSN1d
The Soft, Buttery Mints I Always Make for Holidays and Special GatheringsButter mints remind me of holiday tables and special occasions when there was always a little dish of pastel-colored mints ...
For Kansas residents, Laura Little’s represents something beyond a place to satisfy sugar cravings. It stands as a testament ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results